Equities
Health CareMedical Equipment and Services
  • Price (AUD)298.23
  • Today's Change5.21 / 1.78%
  • Shares traded89.40k
  • 1 Year change+13.52%
  • Beta0.7215
Data delayed at least 20 minutes, as of Nov 22 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy0
Outperform3
Hold9
Sell2
Strong Sell0

Share price forecast in AUD

The 13 analysts offering 12 month price targets for Cochlear Ltd have a median target of 300.02, with a high estimate of 345.00 and a low estimate of 229.12. The median estimate represents a 0.60% increase from the last price of 298.23.
High15.7%345.00
Med0.6%300.02
Low-23.2%229.12

Dividends in AUD

In 2024, Cochlear Ltd reported a dividend of 4.10 AUD, which represents a 24.24% increase over last year. The 14 analysts covering the company expect dividends of 4.51 AUD for the upcoming fiscal year, an increase of 9.98%.
Div growth (TTM)24.24%
More ▼

Earnings history & estimates in AUD

Cochlear Ltd reported annual 2024 earnings of 5.88 per share on Aug 14, 2024.
Average growth rate+23.39%
More ▼

Revenue history & estimates in AUD

Cochlear Limited had revenues for the full year 2024 of 2.24bn. This was 14.31% above the prior year's results.
Average growth rate+14.12%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.